相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation
Marcus Borenas et al.
EMBO JOURNAL (2021)
Spatiotemporal profiling of cytosolic signaling complexes in living cells by selective proximity proteomics
Mi Ke et al.
NATURE COMMUNICATIONS (2021)
Targeting netrin-3 in small cell lung cancer and neuroblastoma
Shan Jiang et al.
EMBO MOLECULAR MEDICINE (2021)
Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway
Yun Liu et al.
CELL DEATH & DISEASE (2021)
Proteomic investigation of Cbl and Cbl-b in neuroblastoma cell differentiation highlights roles for SHP-2 and CDK16
Anna-Kathrine Pedersen et al.
ISCIENCE (2021)
The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma
Hsiu-Hao Chang et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
NRAS Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS-MAPK Pathway in Neuroblastoma
Ivette Valencia-Sama et al.
CANCER RESEARCH (2020)
Targeting anaplastic lymphoma kinase in neuroblastoma
Ganesh Umapathy et al.
APMIS (2019)
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Yuxing Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
NUMB regulates the endocytosis and activity of the anaplastic lymphoma kinase in an isoform-specific manner
Ran Wei et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
The pseudokinases SgK269 and SgK223: A novel oncogenic alliance in human cancer
Rachelle L. O'Rourke et al.
CELL ADHESION & MIGRATION (2018)
SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
Leila Dardaei et al.
NATURE MEDICINE (2018)
Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis
Lucille Lopez-Delisle et al.
ONCOGENE (2018)
ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells
Andrey Fadeev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1-and RAS-driven cancers
Robert J. Nichols et al.
NATURE CELL BIOLOGY (2018)
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
Kristina B. Emdal et al.
SCIENCE SIGNALING (2018)
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways
Jimmy Van den Eynden et al.
SCIENCE SIGNALING (2018)
Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation
Maretoshi Hirai et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk
Elizabeth S. Mo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas
Ganesh Umapathy et al.
SCIENCE SIGNALING (2017)
Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation
Xiaoling Zhang et al.
CELL REPORTS (2017)
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas
Ganesh Umapathy et al.
SCIENCE SIGNALING (2017)
Genetic inhibition of Anaplastic Lymphoma Kinase rescues cognitive impairments in Neurofibromatosis 1 mutant mice
Joseph B. Weiss et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen et al.
NATURE (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
2016 update of the PRIDE database and its related tools (vol 44, pg D447, 2016)
Juan Antonio Vizcaino et al.
NUCLEIC ACIDS RESEARCH (2016)
Meet the neighbors: Mapping local protein interactomes by proximity-dependent labeling with BioID
Renata Varnaite et al.
PROTEOMICS (2016)
Protein Neighbors and Proximity Proteomics
Johanna S. Rees et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al.
NATURE GENETICS (2015)
Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions
Andrey V. Reshetnyak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
Jikui Guan et al.
ELIFE (2015)
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Gudrun Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma
Ganesh Umapathy et al.
SCIENCE SIGNALING (2014)
Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells
Kamaraj Sattu et al.
FEBS JOURNAL (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Bengt Hallberg et al.
NATURE REVIEWS CANCER (2013)
A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells
Kyle J. Roux et al.
JOURNAL OF CELL BIOLOGY (2012)
Internalization and Down-Regulation of the ALK Receptor in Neuroblastoma Cell Lines upon Monoclonal Antibodies Treatment
Pierre Mazot et al.
PLOS ONE (2012)
NUMB-ing down cancer by more than just a NOTCH
Salvatore Pece et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy
Tommy Martinsson et al.
CANCER RESEARCH (2011)
The UNC5C Netrin Receptor Regulates Dorsal Guidance of Mouse Hindbrain Axons
Doyeun Kim et al.
JOURNAL OF NEUROSCIENCE (2011)
The Receptor Tyrosine Kinase Alk Controls Neurofibromin Functions in Drosophila Growth and Learning
Jean Y. Gouzi et al.
PLOS GENETICS (2011)
2p24 Gain Region Harboring MYCN Gene Compared with MYCN Amplified and Nonamplified Neuroblastoma Biological and Clinical Characteristics
Marta Jeison et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome
Michael Holzel et al.
CELL (2010)
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
Sara De Brouwer et al.
CLINICAL CANCER RESEARCH (2010)
Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)
Xian Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells
C. Schoenherr et al.
ONCOGENE (2010)
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Helena Caren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Prominent expression of FRS2β protein in neural cells and its association with intracellular vesicles
Yuriko Minegishi et al.
FEBS LETTERS (2009)
Netrin-1 acts as a survival factor for aggressive neuroblastoma
Celine Delloye-Bourgeois et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor
Weiwei Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Caren et al.
BIOCHEMICAL JOURNAL (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Netrin-1 mediates neuronal survival through PIKE-L interaction with the dependence receptor UNC5B
Xiaoling Tang et al.
NATURE CELL BIOLOGY (2008)
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration
Claudia Voena et al.
CANCER RESEARCH (2007)
ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation
Joffrey Degoutin et al.
FEBS LETTERS (2007)
The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor
JB Easton et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Association with Hrs is required for the early endosomal localization, stability, and function of STAM
E Mizuno et al.
JOURNAL OF BIOCHEMISTRY (2004)
Mapping netrin receptor binding reveals domains of Unc5 regulating its tyrosine phosphorylation
RP Kruger et al.
JOURNAL OF NEUROSCIENCE (2004)
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
A Motegi et al.
JOURNAL OF CELL SCIENCE (2004)
The dependence receptors DCC and UNC5H as a link between neuronal guidance and survival
P Mehlen et al.
BIOLOGY OF THE CELL (2003)
分享论文
